Skip to main content
Figure 10 | Journal of Ovarian Research

Figure 10

From: Serum folate receptor alpha, mesothelin and megakaryocyte potentiating factor in ovarian cancer: association to disease stage and grade and comparison to CA125 and HE4

Figure 10

Performance of multi-marker panels for the discrimination of ovarian cancer patients (n=176) from healthy controls (n=20). ROC showing the performance of a four-biomarker panel, consisting of CA125, FRA, MSLN and MPF) in differentiating all ovarian cancer patients from healthy controls. The AUCs of the panel (AUC=0.91) was significantly improved over that of CA125 alone (AUC=0.84).

Back to article page